Efficacy and Safety of JM-010 in PD With Levodopa-Induced Dyskinesia

Mise à jour : Il y a 4 ans
Référence : NCT02439203

Femme et Homme

Extrait

The purpose of a randomized, double-blind, placebo-controlled, 2-way crossover study is to evaluate the efficacy, safety/tolerability and pharmacokinetics of JM-010 for the treatment of subjects with Parkinson's Disease (PD) with levodopa-induced dyskinesia (LID).


Critère d'inclusion

  • Parkinson's disease ,Levodopa Induced Dyskinesia (LID)

Liens